CDK4/6 and PI3K inhibitors: A new promise for patients with HER2‐positive breast cancer

European Journal of Clinical Investigation ◽

10.1111/eci.13535 ◽

2021 ◽

Author(s):

Elisa Agostinetto ◽

Véronique Debien ◽

Guilherme Nader Marta ◽

Matteo Lambertini ◽

Martine Piccart‐Gebhart ◽

...

Keyword(s):

Breast Cancer ◽

Her2 Positive ◽

Pi3k Inhibitors ◽

Her2 Positive Breast Cancer ◽

Positive Breast Cancer

Download Full-text

Review of treatment strategies for HER2 positive breast cancer and their implementation in a major Swiss hospital

10.1055/s-0040-1710671 ◽

2020 ◽

Author(s):

F Geissler ◽

M Vetter ◽

A Schoetzau ◽

C Montavon ◽

C Kurzeder ◽

...

Keyword(s):

Breast Cancer ◽

Treatment Strategies ◽

Her2 Positive ◽

Her2 Positive Breast Cancer ◽

Positive Breast Cancer

Download Full-text

Outcome impact of PIK3CA mutations in HER2-positive breast cancer patients treated with neoadjuvant chemotherapy: Sequential analysis

10.26226/morressier.596dfd55d462b80292386fa4 ◽

2017 ◽

Author(s):

You-Jeong Seo

Keyword(s):

Breast Cancer ◽

Neoadjuvant Chemotherapy ◽

Cancer Patients ◽

Sequential Analysis ◽

Breast Cancer Patients ◽

Her2 Positive ◽

Pik3ca Mutations ◽

Her2 Positive Breast Cancer ◽

Positive Breast Cancer

Download Full-text

Hypoxia up-regulates ID proteins in Luminal and HER2-positive breast cancer cell lines

10.26226/morressier.5b4709836f4cb30010951ad8 ◽

2018 ◽

Author(s):

Gloria Peiro Cabrera

Keyword(s):

Breast Cancer ◽

Cancer Cell ◽

Breast Cancer Cell ◽

Breast Cancer Cell Lines ◽

Her2 Positive ◽

Her2 Positive Breast Cancer ◽

Id Proteins ◽

Positive Breast Cancer Cell ◽

Positive Breast Cancer

Download Full-text

FDA approves fam-trastuzumab deruxtecan-nxki for unresectable or metastatic HER2-positive breast cancer

Case Medical Research ◽

10.31525/cmr-24bd324 ◽

2019 ◽

Author(s):

Keyword(s):

Breast Cancer ◽

Her2 Positive ◽

Her2 Positive Breast Cancer ◽

Positive Breast Cancer

Download Full-text

FDA approves new treatment option for patients with HER2-positive breast cancer who have progressed on available therapies

Case Medical Research ◽

10.31525/cmr-24bb59f ◽

2019 ◽

Author(s):

Keyword(s):

Breast Cancer ◽

Treatment Option ◽

Her2 Positive ◽

Her2 Positive Breast Cancer ◽

New Treatment ◽

Positive Breast Cancer

Download Full-text

FDA approves new treatment option for patients with HER2-positive breast cancer who have progressed on available therapies

Case Medical Research ◽

10.31525/cmr-24bb467 ◽

2019 ◽

Author(s):

Keyword(s):

Breast Cancer ◽

Treatment Option ◽

Her2 Positive ◽

Her2 Positive Breast Cancer ◽

New Treatment ◽

Positive Breast Cancer

Download Full-text

Neoadjuvant Study of Pyrotinib and Trastuzumab Plus Chemotherapy in Patients With HER2 Positive Breast Cancer

Case Medical Research ◽

10.31525/ct1-nct03847818 ◽

2000 ◽

Author(s):

Keyword(s):

Breast Cancer ◽

Her2 Positive ◽

Her2 Positive Breast Cancer ◽

Positive Breast Cancer

Download Full-text

Phase 1 Study of FS-1502 in Patients With HER2 Expressed Advanced Solid Tumors and Local Advanced or Metastatic, HER2 Positive Breast Cancer.

Case Medical Research ◽

10.31525/ct1-nct03944499 ◽

2019 ◽

Author(s):

Keyword(s):

Breast Cancer ◽

Solid Tumors ◽

Phase 1 ◽

Advanced Solid Tumors ◽

Her2 Positive ◽

Phase 1 Study ◽

Her2 Positive Breast Cancer ◽

Local Advanced ◽

Positive Breast Cancer

Download Full-text

A Study Of SIBP-01 Or CN-Trastuzumab Plus Docetaxel And Carboplatin In HER2 Positive Breast Cancer

Case Medical Research ◽

10.31525/ct1-nct03989037 ◽

2019 ◽

Author(s):

Keyword(s):

Breast Cancer ◽

Her2 Positive ◽

Her2 Positive Breast Cancer ◽

Positive Breast Cancer

Download Full-text

Copanlisib in Combination With T-DM1 in Pretreated Unresectable Locally Advanced or Metastatic HER2-positive Breast Cancer

Case Medical Research ◽

10.31525/ct1-nct04042051 ◽

2019 ◽

Author(s):

Keyword(s):

Breast Cancer ◽

Locally Advanced ◽

Her2 Positive ◽

Her2 Positive Breast Cancer ◽

Positive Breast Cancer

Download Full-text